Cargando…
Losartan Alleviates the Side Effects and Maintains the Anticancer Activity of Axitinib
Axitinib is one of the most potent inhibitors of the vascular endothelial growth factor (VEGF) receptor and shows strong antitumor activity toward various malignant tumors. However, its severe side effects affect the quality of life and prognosis of patients. Losartan, which functions as a typical a...
Autores principales: | Fu, Ying, Saxu, Rengui, Ridwan, Kadir Ahmad, Yao, Jiaping, Chen, Xiaoxuan, Xu, Xueping, Zheng, Weida, Yu, Peng, Teng, Yuou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101101/ https://www.ncbi.nlm.nih.gov/pubmed/35566115 http://dx.doi.org/10.3390/molecules27092764 |
Ejemplares similares
-
Selenium substituted axitinib reduces axitinib side effects and maintains its anti-renal tumor activity
por: Fu, Ying, et al.
Publicado: (2022) -
Anastatin Derivatives Alleviate Myocardial Ischemia-Reperfusion Injury via Antioxidative Properties
por: Fu, Ying, et al.
Publicado: (2021) -
Axitinib Rechallenge Restores the Anticancer Effect after Nivolumab: A Case Report
por: Chang, Yueh-Shih, et al.
Publicado: (2023) -
Axitinib in Metastatic Renal Cell Carcinoma
por: Mittal, Kriti, et al.
Publicado: (2012) -
Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)